The Culprit Behind HBV-Infected Hepatocytes: NTCP

Area of Science:

• Hepatology
• Virology
• Molecular Biology

Background:

• Hepatitis B virus (HBV) causes over 250 million chronic infections globally, leading to liver inflammation, cirrhosis, and hepatocellular carcinoma (HCC).
• Sodium taurocholate co-transporting polypeptide (NTCP) is a key bile acid transporter in hepatocytes, identified as the entry receptor for HBV and hepatitis delta virus (HDV).
• NTCP's role in initiating HBV infection and subsequent metabolic changes in hepatocytes is critical for viral entry.

Purpose of the Study:

• To review the regulatory mechanisms of HBV pre-S1 binding to NTCP.
• To elucidate NTCP's function in HBV internalization.
• To discuss the transcriptional and translational regulation of NTCP expression and its therapeutic targeting.

Main Methods:

• Literature review of studies on HBV-NTCP interactions.
• Analysis of signaling pathways regulating HBV entry.
• Examination of NTCP expression and regulation.
• Review of clinical data on NTCP inhibitors.

Main Results:

• NTCP is essential for HBV and HDV entry into hepatocytes.
• HBV binding to NTCP triggers signaling pathways that facilitate viral internalization.
• NTCP expression is regulated at transcriptional and translational levels.
• Clinical drugs targeting NTCP are under investigation for HBV treatment.

Conclusions:

• NTCP is a crucial mediator of HBV infection initiation and progression.
• Targeting NTCP presents a promising therapeutic strategy for chronic HBV infection.
• Further research into NTCP regulation and drug development is warranted to assess safety and efficacy.